Category: 2018
December | 2018
TEL AVIV, Israel and BETHESDA, Maryland, Dec. 11, 2018 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a world leader in personalized cann
November | 2018
TEL-AVIV, Israel, Nov. 28, 2017 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (CNBX) announced today that it has received a new research license from
November | 2018
TEL AVIV, Israel and BETHESDA, Maryland, Nov. 28, 2018 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a world leader in personalized cann
November | 2018
TEL AVIV, Israel and BETHESDA, Maryland, Nov. 27, 2018 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabin
November | 2018
PHOENIX, Ariz., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX) (the “Company”) is a U.S public company that is developin
November | 2018
TEL AVIV, Israel and BETHESDA, Maryland, Nov. 1, 2018 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabin
October | 2018
TEL AVIV, Israel and BETHESDA, Maryland, Oct. 25, 2018 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabin
October | 2018
TEL AVIV, Israel and BETHESDA, Maryland, Oct. 19, 2018 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabin
October | 2018
TEL AVIV, Israel and BETHESDA, Maryland, Oct. 16, 2018 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabi
October | 2018
TEL AVIV, Israel and BETHESDA, Maryland, Oct. 9, 2018 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabino
September | 2018
TEL AVIV, Israel and BETHESDA, Maryland, September 24, 2018 /PRNewswire/ -- CANNABICS PHARMACEUTICALS INC. (OTCQB: CNBX) ("Cannabics" or the
September | 2018
TEL AVIV, Israel and BETHESDA, Maryland, Sept. 21, 2018 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized can
September | 2018
TEL AVIV, Israel and BETHESDA, Maryland, Sept. 18, 2018 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTC: CNBX), a leader in personalized cannabino
September | 2018
TEL AVIV, Israel and BETHESDA, Maryland, Sept. 14, 2018 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannab
September | 2018
TEL AVIV, Israel and BETHESDA, Maryland, Sept. 5, 2018 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabin
August | 2018
TEL AVIV, Israel, August 28, 2018 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine
August | 2018
Aug. 22, 2018, TEL AVIV, Israel and BETHESDA, Maryland /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabin
August | 2018
TEL AVIV, Israel and BETHESDA, Maryland, Aug. 14, 2018 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabin
August | 2018
TEL AVIV, Israel and BETHESDA, Maryland, Aug. 10, 2018 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabin
August | 2018
TEL AVIV, Israel and BETHESDA, Maryland, August 9, 2018 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabi
August | 2018
TEL AVIV, Israel and BETHESDA, Maryland, Aug. 2, 2018 /PRNewswire/ -- Dear Fellow Shareholders, I am pleased to announce that we have ente
July | 2018
TEL AVIV, Israel and BETHESDA, Maryland, July 11, 2018 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabin
July | 2018
TEL AVIV, Israel and BETHESDA, Maryland, July 3, 2018 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), leader in personalized cannabi
June | 2018
TEL AVIV, Israel and BETHESDA, Maryland, June 29, 2018 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabis
June | 2018
TEL AVIV, Israel and BETHESDA, Maryland, June 26, 2018 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabi
May | 2018
TEL AVIV, Israel and BETHESDA, Maryland, May 24, 2018 /PRNewswire/ -- Cannabics Pharmaceuticals (OTCQB: CNBX), a US bio-pharma company develo
May | 2018
TEL AVIV, Israel and BETHESDA, Maryland, May 22, 2018 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (CNBX), leader in cannabinoid diagnostic tests fo
May | 2018
TEL AVIV, Israel and BETHESDA, Maryland, May 2, 2018 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (CNBX), leader in cannabinoid diagnostic
April | 2018
Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in cannabinoid diagnostics for the personalized treatment of cancer, today announced the receip
March | 2018
TEL AVIV, Israel and BETHESDA, Maryland, March 29, 2018 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (CNBX), a leader in cannabinoid diagno
February | 2018
TEL AVIV, Israel, February 28, 2018 /PRNewswire/ -- Cannabics Pharmaceuticals, Inc. (OTCQB: CNBX) announced today that Dr. Moran Grinberg, VP
February | 2018
TEL AVIV, Israel and BETHESDA, Maryland, February 20, 2018 Cannabics Pharmaceuticals Inc. (CNBX), a US public biotechnology company dedicated
January | 2018
TEL-AVIV, Israel, January 2, 2018 Cannabics Pharmaceuticals Inc. (OTCQB: CNBX) announced today that it has filed an international patent appl
November | 2017
TEL-AVIV, Israel, November 8, 2017 Cannabics Pharmaceuticals Inc. (CNBX) announced today that it has filed the first of a cluster of patent a